<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
CRESCENDO PHARMACEUTICALS CORPORATION.
- -------------------------------------------------------------------------------
(Name of Issuer)
CLASS A COMMON STOCK, $.01 PAR VALUE PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
225637 10 7
- --------------------------------------------------------------------------------
(CUSIP Number)
DECEMBER 31, 1998
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 2
Page 2 of 9 Pages
- --------------------------------------------------------------------------------
CUSIP No. 225637 10 7 13G
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (entities only)
WOODBOURNE PARTNERS, L.P.
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Citizenship or Place of Organization
MISSOURI
- --------------------------------------------------------------------------------
Number of 5 Sole Voting Power
Shares -0-
---------------------------------------------------
Beneficially 6 Shared Voting Power
-0-
Owned by
---------------------------------------------------
7 Sole Dispositive Power
Each
-0-
Reporting
---------------------------------------------------
8 Shared Dispositive Power
Person With
-0-
- --------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
895,000
- --------------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
- --------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
18.0%
- --------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
PN
- --------------------------------------------------------------------------------
<PAGE> 3
Page 3 of 9 Pages
- --------------------------------------------------------------------------------
CUSIP No. 225637 10 7 13G
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (entities only)
FORSYTH JOINT VENTURE
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Citizenship or Place of Organization
MISSOURI
- --------------------------------------------------------------------------------
Number of 5 Sole Voting Power
Shares -0-
---------------------------------------------------
Beneficially 6 Shared Voting Power
-0-
Owned by
---------------------------------------------------
7 Sole Dispositive Power
Each
-0-
Reporting
---------------------------------------------------
8 Shared Dispositive Power
Person With
-0-
- --------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
50,000
- --------------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
- --------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
1.0%
- --------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
OO
- --------------------------------------------------------------------------------
<PAGE> 4
Page 4 of 9 Pages
- --------------------------------------------------------------------------------
CUSIP No. 225637 10 7 13G
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (entities only)
CLAYTON MANAGEMENT COMPANY
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Citizenship or Place of Organization
MISSOURI
- --------------------------------------------------------------------------------
Number of 5 Sole Voting Power
Shares 945,000
---------------------------------------------------
Beneficially 6 Shared Voting Power
-0-
Owned by
---------------------------------------------------
7 Sole Dispositive Power
Each
945,000
Reporting
---------------------------------------------------
8 Shared Dispositive Power
Person With
-0-
- --------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
945,000
- --------------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
- --------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
19.0%
- --------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
CO
- --------------------------------------------------------------------------------
<PAGE> 5
Page 5 of 9 Pages
- --------------------------------------------------------------------------------
CUSIP No. 225637 10 7 13G
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (entities only)
JOHN D. WEIL
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Citizenship or Place of Organization
MISSOURI
- --------------------------------------------------------------------------------
Number of 5 Sole Voting Power
Shares 945,000
---------------------------------------------------
Beneficially 6 Shared Voting Power
-0-
Owned by
---------------------------------------------------
7 Sole Dispositive Power
Each
945,000
Reporting
---------------------------------------------------
8 Shared Dispositive Power
Person With
-0-
- --------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
945,000
- --------------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
- --------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
19.0%
- --------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
IN
- --------------------------------------------------------------------------------
<PAGE> 6
Page 6 of 9 Pages
- --------------------------------------------------------------------------------
CUSIP No. 225637 10 7 13G
- --------------------------------------------------------------------------------
AMENDMENT NO. 1 TO SCHEDULE 13G
The Reporting Person reported the acquisition of shares of Class A
Common Stock, par value $.01 per share ("Stock"), of Crescendo Pharmaceuticals
Corporation, a Delaware corporation ("Issuer"),1454 Page Mill Road, Palo Alto,
California 94304, in an initial filing of this Schedule 13G on March 6, 1998. In
this regard, Item 2 and Item 4 are hereby amended as follow. All other items are
unchanged from the initial filing.
ITEM 2(A) Name of Person Filing:
(a) WOODBOURNE PARTNERS, L.P. ("WOODBOURNE")
(b) FORSYTH JOINT VENTURE ("FORSYTH")
(c) CLAYTON MANAGEMENT COMPANY ("CLAYTON")
(d) JOHN D. WEIL ("WEIL")
ITEM 2(B) Address of Principal Business Office:
(a) 200 N. BROADWAY, SUITE 825
ST. LOUIS, MISSOURI 63102
(b) 200 N. BROADWAY, SUITE 825
ST. LOUIS, MISSOURI 63102
(c) 200 N. BROADWAY, SUITE 825
ST. LOUIS, MISSOURI 63102
(d) 200 N. BROADWAY, SUITE 825
ST. LOUIS, MISSOURI 63102
ITEM 2(C) Place of Organization; Citizenship:
(a) WOODBOURNE IS A LIMITED PARTNERSHIP ORGANIZED UNDER
MISSOURI LAW.
(b) FORSYTH IS A JOINT VENTURE AMONG THREE CHARITABLE
FOUNDATIONS GOVERNED UNDER MISSOURI LAW.
(c) CLAYTON IS A CORPORATION ORGANIZED UNDER MISSOURI LAW
AND IS THE GENERAL PARTNER OF WOODBOURNE AND THE
MANAGER OF FORSYTH.
(d) WEIL, THE SOLE DIRECTOR AND SOLE SHAREHOLDER OF
CLAYTON, IS AN INDIVIDUAL RESIDING IN MISSOURI. WEIL
AND CERTAIN OF HIS FAMILY MEMBERS ARE THE TRUSTEES OF
THE CHARITABLE FOUNDATIONS THAT FORMED FORSYTH.
ITEM 2(D) Title of Class of Securities:
CLASS A COMMON STOCK, PAR VALUE $0.01 PER SHARE
ITEM 2(E) CUSIP Number:
225637 10 7
<PAGE> 7
Page 7 of 9 Pages
- --------------------------------------------------------------------------------
CUSIP No. 225637 10 7 13G
- --------------------------------------------------------------------------------
ITEM 4. Ownership.
<TABLE>
<CAPTION>
WOODBOURNE FORSYTH CLAYTON WEIL
---------- ------- ------- -------
<S> <C> <C> <C> <C>
(a) Amount beneficially owned: 895,000 50,000 945,000 945,000
(b) Percent of Class: 18.0% 1.0% 19.0% 19.0%
(c) Number of Shares as to which the person has:
(i) Sole power to vote or direct
the vote: -0- -0- 945,000 945,000
(ii) Shared power to vote or direct
the vote: -0- -0- -0- -0-
(iii) Sole power to dispose or to
direct the disposition of: -0- -0- 945,000 945,000
(iv) Shared power to dispose or to
direct the disposition of: -0- -0- -0- -0-
</TABLE>
<PAGE> 8
Page 8 of 9 Pages
- --------------------------------------------------------------------------------
CUSIP No. 225637 10 7 13G
- --------------------------------------------------------------------------------
ITEM 10. Certification.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
Dated: February 16, 1999 WOODBOURNE PARTNERS, L.P.,
by its General Partner,
CLAYTON MANAGEMENT COMPANY
/s/ John D. Weil
-------------------------------
John D. Weil, President
Dated: February 16, 1999 FORSYTH JOINT VENTURE,
by its Manager, CLAYTON
MANAGEMENT COMPANY
/s/ John D. Weil
-------------------------------
John D. Weil, President
Dated: February 16, 1999 CLAYTON MANAGEMENT COMPANY
/s/ John D. Weil
-------------------------------
John D. Weil, President
Dated: February 16, 1999 /s/ John D. Weil
-------------------------------
John D. Weil
<PAGE> 9
Page 9 of 9 Pages
- --------------------------------------------------------------------------------
CUSIP No. 225637 10 7 13G
- --------------------------------------------------------------------------------
EXHIBIT A TO SCHEDULE 13G
AGREEMENT PURSUANT TO RULE 13d-1(K)(1)
The undersigned persons, on February 16, 1999, agree and consent to the
joint filing on their behalf of this Schedule 13G in connection with their
beneficial ownership of the Class A Common Stock of Crescendo Pharmaceuticals
Corporation.
WOODBOURNE PARTNERS, L.P.,
by its General Partner,
CLAYTON MANAGEMENT COMPANY
/s/ John D. Weil
-------------------------------
John D. Weil, President
WOODBOURNE PARTNERS, L.P.,
by its Manager, CLAYTON
MANAGEMENT COMPANY
/s/ John D. Weil
-------------------------------
John D. Weil, President
CLAYTON MANAGEMENT COMPANY
/s/ John D. Weil
-------------------------------
John D. Weil, President
/s/ John D. Weil
-------------------------------
John D. Weil
